Endolumik, Inc. is conducting a pilot study to evaluate its Endolumik Gastric Calibration Tube, a novel fluorescence-guided device intended to enhance visualization during bariatric surgeries. The study aims to confirm the device's performance against predicate devices and gather end-user feedback prior to a 510(k) submission to the FDA. The bariatric surgery market is growing, driven by increasing obesity rates and the demand for effective surgical interventions. The successful completion of this pilot study could position Endolumik favorably against competitors in the surgical device market, particularly in the niche of bariatric surgery, where innovation in surgical tools is critical for improving patient outcomes. The collaboration with recognized institutions like West Virginia University and Duke University enhances credibility and may facilitate future partnerships or funding opportunities.